<b>Viriom</b> Obtains First Market Approval Of Elsulfavirine (Elpida) For Treatment Of HIV-1 Infection In Russia - BioLegacy Research

<b>Viriom</b> Obtains First Market Approval Of Elsulfavirine (Elpida) For Treatment Of HIV-1 Infection In Russia

Post author:Sam
Post published:July 24, 2017
Post category:BioPharma

Life Sciences Jobs …
Source: BioSpace